| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013974493 |
| P356 | DOI | 10.1007/BF00145359 |
| P698 | PubMed publication ID | 1505660 |
| P2093 | author name string | G. Assmann | |
| H. Schulte | |||
| P2860 | cites work | Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men | Q70448909 |
| Consensus conference: Treatment of hypertriglyceridemia | Q70927421 | ||
| Interpreting multiple logistic regression coefficients in prospective observational studies | Q71344928 | ||
| Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population | Q71707895 | ||
| Serum triglycerides in health and in ischemic heart disease | Q72559601 | ||
| SERUM LIPIDS DURING THE COURSE OF AN ACUTE MYOCARDIAL INFARCTION AND ONE YEAR AFTERWARDS | Q76589062 | ||
| Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease | Q35711239 | ||
| Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease | Q39241018 | ||
| Premature death and associated risk factors in urban middle-aged men | Q39340538 | ||
| Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study | Q41473308 | ||
| The triglyceride issue: a view from Framingham | Q44822390 | ||
| Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. | Q44909038 | ||
| Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia | Q46793567 | ||
| Borderline fasting hypertriglyceridemia: absence of excess risk of all-cause and cardiovascular disease mortality in healthy men without hypercholesterolemia. | Q51630835 | ||
| Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. | Q51639486 | ||
| Association of serum lipids and obesity with cardiovascular mortality | Q55434359 | ||
| [Prediction and early diagnosis of coronary disease. Prospective epidemiologic study of industrial workers in Westphalia] | Q67245795 | ||
| The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease | Q67987025 | ||
| Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society | Q69749258 | ||
| Risk factors in middle age that predict early and late onset of coronary heart disease | Q69949126 | ||
| Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study | Q70104594 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | triglyceride | Q186319 |
| circulatory system | Q11068 | ||
| P304 | page(s) | 99-103 | |
| P577 | publication date | 1992-05-01 | |
| P1433 | published in | European Journal of Epidemiology | Q5412723 |
| P1476 | title | The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study | |
| P478 | volume | 8 Suppl 1 |
| Q36455898 | Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies |
| Q47720534 | Associations of protein C and protein S with serum lipid concentrations |
| Q37921312 | Biomarkers for predicting postmenopausal coronary heart disease |
| Q37610385 | Cardiovascular aspects of menopausal hormone replacement therapy |
| Q40394318 | Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment |
| Q37354315 | Diet and haemostatic processes |
| Q46199518 | Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids |
| Q43739783 | Fenofibrate-Induced elevation in serum creatinine |
| Q37044313 | Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease |
| Q36946783 | Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention |
| Q46418500 | Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia |
| Q36739259 | Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? |
| Q36816891 | Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty |
| Q89585559 | Individuals with obesity but no other metabolic risk factors are not at significantly elevated all-cause mortality risk in men and women |
| Q37385184 | Managing diabetic dyslipidemia: beyond statin therapy |
| Q35582273 | NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels |
| Q51322784 | Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway. |
| Q44978193 | Risk factors for cardiovascular disease in the elderly in Taiwan |
| Q43267027 | The metabolic syndrome in women |
| Q26745946 | Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease |
Search more.